A regioisomeric phenanthroquinoxaline-based small molecular defect passivation layer for enhanced efficiency in stable perovskite solar cells

Abstract

Solution processability and temperature-induced fast crystallization lead to various defects at the surface of perovskite films, which act as the epicenters of non-radiative recombination loss. Therefore, eliminating these surface defects through effective passivation is of utmost importance. Herein, we introduce two small-molecular donor–acceptor–donor (D–A–D) interface passivators, namely, 4,4′-(dipyrido[3,2-a:2′,3′-c]phenazine-10,13-diyl)bis(N,N-bis(4-methoxyphenyl)aniline) (PNQP) and 4,4′-(dipyrido[3,2-a:2′,3′-c]phenazine-11,12-diyl)bis(N,N-bis(4-methoxyphenyl)aniline) (PNQO), by varying the substitution position of the donor triphenylamine motifs. By simply relocating the donor arms in PNQO, the π-conjugated heterocyclic core is pushed outward, establishing direct contact with the perovskite surface and significantly strengthening the perovskite/HTM interfacial interaction while reducing interfacial defect recombination. For PNQO, the enhanced dipole moment leads to a better charge-separated state and improved hole mobility, facilitating the healing of surface defects by chelating with uncoordinated Pb2+ through a Lewis acid–base interaction. The modulation of regioisomeric configurations to enhance passivation efficacy has been systematically investigated through a combination of comprehensive theoretical and experimental approaches. Remarkably, the PNQO-treated PSCs delivered a champion power conversion efficiency (PCE) of 31.50% under an indoor 1000 lx white LED, which is higher than that of the control device without passivation layer treatment (25.32%). In addition, the PNQO-treated PSCs exhibited an improved PCE of 18.74% under AM 1.5G illumination, which is higher than that of the control device (16.64%). After 1560 hours of storage under ambient conditions, the unencapsulated device retained 91% of its initial PCE, outperforming the control device, which could achieve only 41%. This study establishes a design strategy for a small molecular passivation layer to enhance the efficiency and stability of PSCs in the future.

Graphical abstract: A regioisomeric phenanthroquinoxaline-based small molecular defect passivation layer for enhanced efficiency in stable perovskite solar cells

Supplementary files

Transparent peer review

To support increased transparency, we offer authors the option to publish the peer review history alongside their article.

View this article’s peer review history

Article information

Article type
Paper
Submitted
27 Feb 2026
Accepted
10 May 2026
First published
27 May 2026

J. Mater. Chem. C, 2026, Advance Article

A regioisomeric phenanthroquinoxaline-based small molecular defect passivation layer for enhanced efficiency in stable perovskite solar cells

B. Mondal, Y. Taneja, C. Ghosh, R. Singh and S. K. Samanta, J. Mater. Chem. C, 2026, Advance Article , DOI: 10.1039/D6TC00627B

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements